Targeted Therapies | Community Health

Targeted therapies are a groundbreaking approach to cancer treatment, focusing on specific molecules that fuel tumor growth. By interfering with these molecules, targeted therapies can halt cancer progression with fewer side effects than traditional chemotherapy. This approach has revolutionized the field of oncology, offering new hope for patients with various types of cancer. According to the National Cancer Institute, targeted therapies have improved treatment outcomes for patients with certain types of cancer, such as breast cancer and lung cancer. The global market for targeted therapies is expected to reach $85 billion by 2025, with major players like [[pfizer|Pfizer]], [[roche|Roche]], and [[novartis|Novartis]] investing heavily in research and development. As research continues to advance, targeted therapies are likely to play an increasingly important role in cancer treatment, with potential applications in other diseases as well.